Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ELITE PHARMACEUTICALS INC /NV/ | 30,488 | reported | 31 Dec 2005 | tx 2+13,212 |
| Matinas BioPharma Holdings, Inc. | 11,600 | reported | 30 Apr 2025 | tx 1+11,600 |
| Grace Therapeutics, Inc. | 10,000 | reported | 08 Jan 2026 | tx 3+42,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Jan 2026 | GRANT_AWARD | Grace Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 09 May 2025 | GRANT_AWARD | Grace Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Matinas BioPharma Holdings, Inc. | 11,600 | 0.00 USD | deriv |
| 19 Dec 2023 | GRANT_AWARD | Grace Therapeutics, Inc. | 22,500 | 0.00 USD | deriv |
| 31 Dec 2005 | TAX_WITHHOLDING | ELITE PHARMACEUTICALS INC /NV/ | 10,163 | 1.54 USD | |
| 31 Dec 2005 | GRANT_AWARD | ELITE PHARMACEUTICALS INC /NV/ | 3,049 | 3.00 USD | deriv |